You searched for ms-qava – enQuire BioReagents

Anti-Catenin, beta Antibody Clone 5H10

Additionally, this antibody has been validated by MS–QAVA™.

Anti-p21WAF1 Antibody Clone CIP1/823

Additionally, this antibody has been validated by MS–QAVA™.

Anti-Bax Antibody Clone 2D2

$Analysis of Mass Spec data (dashed-line) of fractions stained with Bax MS-QAVA™ monoclonal antibody [Clone: 2D2] (solid-line), reveals that less than 10.4% of signal is attributable to non-specific binding of anti-Bax Anti-Human, Monkey [Clone 2D2] to targets other than BAX protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.$

Additionally, this antibody has been validated by MS–QAVA™.

Anti-Cytokeratin 8/18 Antibody Clone KRT8.18/1346

Additionally, this antibody has been validated by MS–QAVA™.

Anti-CD44 / HCAM Antibody Clone HCAM/918

$Analysis of Mass Spec data (dashed-line) of fractions stained with CD44 / HCAM MS-QAVA™ monoclonal antibody [Clone: HCAM/918] (solid-line), reveals that less than 12.6% of signal is attributable to non-specific binding of anti-CD44 / HCAM Std. Anti-Human, Primate [Clone HCAM/918] to targets other than CD44 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in Jurkat, U202 and HeLa cells.$

Additionally, this antibody has been validated by MS–QAVA™.

Anti-p53 Tumor Suppressor Protein Antibody Clone BP53-12 + DO-7

$Analysis of Mass Spec data (dashed-line) of fractions stained with p53 Tumor Suppressor Protein MS-QAVA™ monoclonal antibody [Clone: BP53-12 + DO-7] (solid-line), reveals that less than 10.8% of signal is attributable to non-specific binding of anti-p53 Tumor Suppressor Protein [Clone BP53-12 + DO-7] to targets other than TP53 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.$

Additionally, this antibody has been validated by MS–QAVA™.

Anti-Cdk1 / p34cdc2 Antibody Clone CDK1/873

$Analysis of Mass Spec data (dashed-line) of fractions stained with Cdk1 / p34cdc2 MS-QAVA™ monoclonal antibody [Clone: CDK1/873] (solid-line), reveals that less than 1.4% of signal is attributable to non-specific binding of anti-Cdk1 / p34cdc2 [Clone CDK1/873] to targets other than CDC2 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in Jurkat, U202 and HeLa cells.$

Additionally, this antibody has been validated by MS–QAVA™.

Anti-MCM7 Antibody Clone MCM7/1468

$Analysis of Mass Spec data (dashed-line) of fractions stained with MCM7 MS-QAVA™ monoclonal antibody [Clone: MCM7/1468] (solid-line), reveals that less than 3.8% of signal is attributable to non-specific binding of anti-MCM7 [Clone: MCM7/1468] to targets other than MCM7 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.$

Additionally, this antibody has been validated by MS–QAVA™.

Anti-ZAP70 Antibody Clone 2F3.2

$Analysis of Mass Spec data (dashed-line) of fractions stained with ZAP70 MS-QAVA™ monoclonal antibody [Clone: 2F3.2] (solid-line), reveals that less than 2.3% of signal is attributable to non-specific binding of anti-ZAP70 [Clone 2F3.2] to targets other than ZAP70 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in Jurkat, U202 and HeLa cells.$

Additionally, this antibody has been validated by MS–QAVA™.

Anti-SUMO-1 Antibody Clone SUMO1/1188

Additionally, this antibody has been validated by MS–QAVA™.

Anti-Cytokeratin 7 Antibody Clone KRT7/1499R

$Analysis of Mass Spec data (dashed-line) of fractions stained with Cytokeratin 7 MS-QAVA™ monoclonal antibody [Clone: KRT7/1499R] (solid-line), reveals that less than 13.6% of signal is attributable to non-specific binding of anti-Cytokeratin 7 [Clone KRT7/1499R] to targets other than KRT7 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.$

Additionally, this antibody has been validated by MS–QAVA™.

Anti-Vimentin Antibody Clone VM1170

Additionally, this antibody has been validated by MS–QAVA™.

Anti-p21WAF1 Antibody Clone DCS-60.2

$Analysis of Mass Spec data (dashed-line) of fractions stained with p21WAF1 MS-QAVA™ monoclonal antibody [Clone: DCS-60.2] (solid-line), reveals that less than 14% of signal is attributable to non-specific binding of anti-p21WAF1 [Clone DCS-60.2] to targets other than CDKN1A protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.$

Additionally, this antibody has been validated by MS–QAVA™.

Anti-p21WAF1 Antibody Clone HJ21

$Analysis of Mass Spec data (dashed-line) of fractions stained with p21WAF1 MS-QAVA™ monoclonal antibody [Clone: HJ21] (solid-line), reveals that less than 11.3% of signal is attributable to non-specific binding of anti-p21WAF1 [Clone HJ21] to targets other than CDKN1A protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.$

Additionally, this antibody has been validated by MS–QAVA™.

Anti-Moesin Antibody Clone MSN/492

Additionally, this antibody has been validated by MS–QAVA™.

Anti-Cytokeratin 8 Antibody Clone H1

Additionally, this antibody has been validated by MS–QAVA™.

Anti-Cytokeratin 7 Antibody Clone OV-TL12/30

Additionally, this antibody has been validated by MS–QAVA™.

Anti-p21WAF1 Antibody Clone WA-1

$Analysis of Mass Spec data (dashed-line) of fractions stained with p21WAF1 MS-QAVA™ monoclonal antibody [Clone: WA-1] (solid-line), reveals that less than 10.9% of signal is attributable to non-specific binding of anti-p21WAF1 [Clone WA-1] to targets other than CDKN1A protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.$

Additionally, this antibody has been validated by MS–QAVA™.

Anti-Cytokeratin 19 Antibody Clone A53-B/A2.26

Additionally, this antibody has been validated by MS–QAVA™.

Anti-Cytokeratin 8/18 Antibody Clone C-43 + DC10

Additionally, this antibody has been validated by MS–QAVA™.